- 10:28 AM Financial stability, climate change top on EU Prez...
- 10:27 AM UK joins G20 push for world levy on banks
- 10:27 AM Britain urges divided G20 to reach climate finance...
- 10:27 AM G20 leaders meet, talk about climate change, world...
- 06:47 PM 'The Sensex will test 14,500 at some point…'
- 04:16 PM See scope for more int'l listings of Indian cos: N...
- 04:12 PM Dollar weakness will boost EMs, commodities ahead:...
- 04:07 PM 'India would've grown at 7% had monsoon not played...
- 03:04 PM Bye-bye Circular 23!
- 03:00 PM CavinKare eyes Rs 100cr revenues from restaurant b...
Portfolio Manager, PN Vijay is not bullish on Ranbaxy.
Vijay told CNBC-TV18, "The residual fair value is around current levels. The open offer excitement is not there; the trouble with Ranbaxy is that their globalization plans are getting into some sort of a problem or the other and we have to see what the new owners would do about that. They lost a couple of Lipitor cases recently I think. So we are not that bullish on Ranbaxy, we like the CRAMs part of the pharma sector more.'
|
Also Read
RSS feed for news about this stock Click here |
Disclosure: It is safe to assume that analyst and his clients may have an investment interest in the above stock/sector
|
Stock Advice
|
|
|
Today's Special Column
with Kishore Biyani
Future Group and the MD of Pantaloon Retail (India) Limited , Group CEO
-
Most Read
-
Most Viewed
- 10 Companies that FIIs love
- 10 companies that MF managers love
- 'The Sensex will test 14,500 at some point…'
- Mahindra Satyam restarts hirings, recalls bench
- Exit Suzlon Energy at Rs 83: Joshi
- 'Bullish' Mark Mobius unfazed by recent market correction
- Sensex ends week 262 pts up, sectors to look at ahead
- SBI cuts deposit rates on slow credit, liquidity glut
- 'The Sensex will test 14,500 at some point…'
Source: CNBC-TV18
- See scope for more int'l listings of Indian cos: NYSE
Source: CNBC-TV18
- Dollar weakness will boost EMs, commodities ahead: HSBC
Source: CNBC-TV18
- 'India would've grown at 7% had monsoon not played truant'
Source: CNBC-TV18
- SBI cuts deposit rates on slow credit, liquidity glut
Source: Business Line
- Aurobindo drug gets US nod
Source: Business Line
- BEML bags Rs 185 cr NCL order
Source: Business Line
- Tatas going global with low-cost housing
Source: Business Line
